Related Experiment Video
Updated: Jul 25, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Inpatient or outpatient initiation of insulin therapy. Experience and cost effective analysis in a suboptimal
1Department of Internal Medicine, Faculty of Medicine, Addis Ababa University, Ethiopia.
In diabetic day-care centres insulin therapy is started on an outpatient basis. However, in areas where such centres are non-existent, diabetics are admitted to hospital for initiation of insulin therapy. As an alternative to this practice, insulin was initiated in 53 outpatients in a suboptimal clinical setting to find out if it is safe, feasible, acceptable and cost-effective. Fifty-one diabetics, admitted for initiation of insulin, served as controls. No significant difference was found in the mean blood glucose before and after treatment, insulin requirement and response to treatment in both groups. Cost analysis showed that outpatient treatment was cheaper than inpatient treatment at third class and indicated a saving of US $273.00 per patient; these costs were much higher for those admitted to expensive classes. None of the outpatients had hypoglycaemia or ketoacidosis during the study period. Thus, outpatient insulin therapy is safe, feasible, acceptable and cost effective; it could be adopted even in places with suboptimal clinical setting.
In diabetic day-care centres insulin therapy is started on an outpatient basis. However, in areas where such centres are non-existent, diabetics are admitted to hospital for initiation of insulin therapy. As an alternative to this practice, insulin was initiated in 53 outpatients in a suboptimal clinical setting to find out if it is safe, feasible, acceptable and cost-effective. Fifty-one diabetics, admitted for initiation of insulin, served as controls. No significant difference was found in the mean blood glucose before and after treatment, insulin requirement and response to treatment in both groups. Cost analysis showed that outpatient treatment was cheaper than inpatient treatment at third class and indicated a saving of US $273.00 per patient; these costs were much higher for those admitted to expensive classes. None of the outpatients had hypoglycaemia or ketoacidosis during the study period. Thus, outpatient insulin therapy is safe, feasible, acceptable and cost effective; it could be adopted even in places with suboptimal clinical setting.
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin Formulations: Types and Delivery
Short-acting insulins are divided into rapid-acting...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Hypoglycemia and Glucagon
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

